Health

Many people with Parkinson’s disease experience hallucinations or delusions in advanced stages. Nuplazid is a targeted treatment developed to address these symptoms without worsening motor function. This article explores its role, effectiveness, and what patients should know in 2025 Read More

Parkinson’s disease is often associated with tremors and mobility issues, but many patients also experience non-motor symptoms such as hallucinations and delusions—especially in later stages. Nuplazid (pimavanserin) is the first FDA-approved treatment specifically developed for Parkinson’s disease psychosis. This article outlines how it works, what makes it different from traditional antipsychotics, and what patients and caregivers should consider in 2025 Read More

Providing home care for a loved one with dementia can be both rewarding and challenging. From managing memory loss and behavioral changes to ensuring safety and routine, the demands are often complex and deeply personal. This article outlines essential considerations for families in 2025—covering home adaptation, caregiver support, and practical strategies to maintain dignity and quality of life Read More

Exploring less invasive treatment options for prostate cancer? Focal laser ablation (FLA) has emerged as a targeted therapy that aims to treat cancerous tissue while preserving surrounding structures. This article examines the role of FLA in 2025, including its clinical context, potential benefits, and key factors to consider when discussing treatment plans with a medical professional Read More